Page last updated: 2024-11-04

eburnamonine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Eburnamonine is an indole alkaloid found in the bark of the African tree Voacanga africana. It has been studied for its potential therapeutic effects, particularly in the treatment of Alzheimer's disease. Research suggests that eburnamonine may act as a cholinesterase inhibitor, a class of drugs that can improve cognitive function by increasing the levels of acetylcholine in the brain. Studies have also investigated its potential as an anti-inflammatory agent and its ability to protect nerve cells from damage. However, further research is needed to fully understand its mechanism of action and to determine its safety and efficacy in humans. Eburnamonine is typically extracted from the plant material or synthesized through chemical processes. '

Cross-References

ID SourceID
PubMed CID3195
CHEBI ID182654
SCHEMBL ID689181
MeSH IDM0066386

Synonyms (20)

Synonym
CHEBI:182654
15-ethyl-1,11-diazapentacyclo[9.6.2.02,7.08,18.015,19]nonadeca-2,4,6,8(18)-tetraen-17-one
14,15-dihydroeburnamenin-14-one
eburnamonine ,
eburnamenin-14(15h)-one
SR-01000638676-1
HMS1664F16
CCG-49205
FT-0635471
(+)-vincamone
SCHEMBL689181
WYJAPUKIYAZSEM-UHFFFAOYSA-N
14,15-dihydroeburnamenin-14-one #
SR-01000638676-5
SR-01000638676-4
sr-01000638676
AKOS025400978
BRD-A60751162-001-01-4
(13ar)-13a-ethyl-2,3,5,6,13,13a-hexahydro-1h-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridin-12(41h)-one
DTXSID10859889

Research Excerpts

Bioavailability

ExcerptReferenceRelevance
" Drug bioavailability of vinburnine seems saved, if not significantly increased by the new formulation, in spite of the very important, and well known interindividual variations of vincamine drug products."( [The oral liquid form of vinburnine: biopharmaceutics].
Gibassier, D; Leverge, R; Sado, PA,
)
0.13
" Drug bioavailability decreases of about 10%, in despite of the very important, and well known, interindividual variations of vincamine drug products."( [The effect of modification of excipients for the bioavailability of vinburnine].
Gibassier, D; Leverge, R; Sado, PA,
)
0.13
", in factors involved in the bioavailability of oxygen (oxygen transport activity and RBC deformability)."( Experimental approach of activity and mechanism(s) of action of drugs used in cerebral metabolic insufficiency. Application to 1-eburnamonine.
Gueguen, M; Hollands, MA; Le Polles, JB; Linee, P; Quiniou, P, 1981
)
0.47

Dosage Studied

ExcerptRelevanceReference
"Biopharmaceutic comparison is achieved between commercialized capsules of vinburnine and drops dosage form intended for geriatric pharmacotherapy."( [The oral liquid form of vinburnine: biopharmaceutics].
Gibassier, D; Leverge, R; Sado, PA,
)
0.13
"Biopharmaceutic comparison is achieved between commercialized capsules of vinburnine and a new dosage form."( [The effect of modification of excipients for the bioavailability of vinburnine].
Gibassier, D; Leverge, R; Sado, PA,
)
0.13
" All of the drugs, with the exception of vinconate, exhibited a monotonic dose-response curve and caused 100% survival at some dose."( Protective effects of vinpocetine and structurally related drugs on the lethal consequences of hypoxia in mice.
King, GA, 1987
)
0.27
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
alkaloidAny of the naturally occurring, basic nitrogen compounds (mostly heterocyclic) occurring mostly in the plant kingdom, but also found in bacteria, fungi, and animals. By extension, certain neutral compounds biogenetically related to basic alkaloids are also classed as alkaloids. Amino acids, peptides, proteins, nucleotides, nucleic acids, amino sugars and antibiotics are not normally regarded as alkaloids. Compounds in which the nitrogen is exocyclic (dopamine, mescaline, serotonin, etc.) are usually classed as amines rather than alkaloids.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (5)

Assay IDTitleYearJournalArticle
AID588519A screen for compounds that inhibit viral RNA polymerase binding and polymerization activities2011Antiviral research, Sep, Volume: 91, Issue:3
High-throughput screening identification of poliovirus RNA-dependent RNA polymerase inhibitors.
AID540299A screen for compounds that inhibit the MenB enzyme of Mycobacterium tuberculosis2010Bioorganic & medicinal chemistry letters, Nov-01, Volume: 20, Issue:21
Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.
AID1794808Fluorescence-based screening to identify small molecule inhibitors of Plasmodium falciparum apicoplast DNA polymerase (Pf-apPOL).2014Journal of biomolecular screening, Jul, Volume: 19, Issue:6
A High-Throughput Assay to Identify Inhibitors of the Apicoplast DNA Polymerase from Plasmodium falciparum.
AID1794808Fluorescence-based screening to identify small molecule inhibitors of Plasmodium falciparum apicoplast DNA polymerase (Pf-apPOL).
AID1159607Screen for inhibitors of RMI FANCM (MM2) intereaction2016Journal of biomolecular screening, Jul, Volume: 21, Issue:6
A High-Throughput Screening Strategy to Identify Protein-Protein Interaction Inhibitors That Block the Fanconi Anemia DNA Repair Pathway.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (47)

TimeframeStudies, This Drug (%)All Drugs %
pre-199017 (36.17)18.7374
1990's8 (17.02)18.2507
2000's5 (10.64)29.6817
2010's13 (27.66)24.3611
2020's4 (8.51)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 21.09

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index21.09 (24.57)
Research Supply Index4.16 (2.92)
Research Growth Index4.66 (4.65)
Search Engine Demand Index21.17 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (21.09)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials7 (12.50%)5.53%
Reviews1 (1.79%)6.00%
Case Studies2 (3.57%)4.05%
Observational0 (0.00%)0.25%
Other46 (82.14%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]